Applicant, as named in the Orange Book

Apothecon

Bristol-Myers Squibb Co · NYSE: BMY

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Products with listed protection

DrugEarliest generic entry

None.

Recent events

  • Ophthaine · Generic approved · ANDA 219294, Micro LabsApproved 20 Oct 2025Detected 25 Oct 2026
  • Prolixin · Generic approved · ANDA 218769, Hetero Labs Ltd IiiApproved 18 Nov 2025Detected 25 Oct 2026
  • Kenalog-10 · Generic approved · ANDA 218601, AlembicApproved 17 Oct 2025Detected 25 Oct 2026
Products without listed protection (3)
DrugEarliest generic entry
Kenalog-10
NDA 012041
triamcinolone acetonide
open now
no listed protection
Kenalog-40
NDA 014901
triamcinolone acetonide
open now
no listed protection
Kenalog-80
NDA 014901
triamcinolone acetonide
open now
no listed protection